Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Language
Publication year range
1.
J Org Chem ; 80(12): 6076-82, 2015 Jun 19.
Article in English | MEDLINE | ID: mdl-26018853

ABSTRACT

Chlorocatechelin A (1) is a structurally unique microbial siderophore containing two units of 4-chloro-2,3-dihydroxybenzoic acid (CDB) and a characteristic acylguanidine structure. Purification from the microbe culture is not an easy task due to the lability of the acylguanidine and its chelating nature. Here we report the first convergent total synthesis and antimicrobial activity of chlorocatechelin A (1). The bis-acylated arginine was constructed using a Schotten-Baumann reaction whereas the CDB component was synthesized from o-vanillin (8). Condensation with an ornithine derivative synthesized from 1-benzyl d-glutamate was followed by deprotection in basic and neutral conditions to complete the total synthesis. We examined the antimicrobial activity of chlorocatechelin A (1) and found that this siderophore was active against desferrioxamine B (DFB)-sensitive microbes including the fish pathogen Pasteurella piscicida.


Subject(s)
Anti-Bacterial Agents/chemical synthesis , Arginine/chemistry , Deferoxamine/antagonists & inhibitors , Dipeptides/chemical synthesis , Siderophores/chemical synthesis , Animals , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Deferoxamine/chemistry , Dipeptides/chemistry , Dipeptides/pharmacology , Fishes/microbiology , Molecular Structure , Pasteurella/drug effects , Pasteurella/pathogenicity , Siderophores/chemistry , Siderophores/pharmacology , Structure-Activity Relationship
2.
Eur J Pharmacol ; 633(1-3): 24-32, 2010 May 10.
Article in English | MEDLINE | ID: mdl-20153315

ABSTRACT

Tolerance to brain injury involves hypoxia-inducible factor-1 (HIF-1) and its target genes as the key pathway mediating a cascade of events including cell survival, energetics, and angiogenesis. In this study, we established the treatment paradigms for an in vitro model of tolerance to oxidative injury in primary astrocytic cultures and further examined the roles for the HIF-1 signalling cascade. Isolated murine astrocytes were preconditioned with sub-toxic concentrations of HIF-1 inducers and subsequently exposed to a H(2)O(2) insult, where changes in cell viability and protein expression were determined. Preconditioning with non-damaging concentrations of desferrioxamine (DFO) and ethyl-3,4-dihydroxybenzoate (EDHB) significantly improved cellular viability after H(2)O(2) injury treatment. Time course studies revealed that DFO and EDHB treatments alone induced sequential activation of HIF-1 signal transduction where nuclear HIF-1alpha protein accumulation was detected as early as 2h, followed by downstream upregulation of intracellular and released VEGF from 4h and 8h onwards, respectively. The protective effects of DFO and EDHB preconditioning against H(2)O(2) injury were abolished by co-treatment with cycloheximide, an inhibitor of protein synthesis. Importantly, when the anti-HIF-1 compound, 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole (YC-1) was used, the cytoprotection and VEGF accumulation produced by DFO and EDHB preconditioning were diminished. These results indicate the essential role of the HIF-1 pathway in our model of tolerance against oxidative injury in cultured astrocytes, and suggest roles for astrocytic HIF-1 expression and VEGF release which may influence the function of surrounding cells and vasculature during oxidative stress-related brain diseases.


Subject(s)
Astrocytes/metabolism , Cell Survival/drug effects , Enzyme Inhibitors/pharmacology , Hypoxia-Inducible Factor 1/metabolism , Oxidative Stress/drug effects , Vascular Endothelial Growth Factor A/metabolism , Animals , Cells, Cultured , Cycloheximide/pharmacology , Cytoprotection/drug effects , Deferoxamine/antagonists & inhibitors , Deferoxamine/pharmacology , Drug Interactions , Hydrogen Peroxide/antagonists & inhibitors , Hydrogen Peroxide/toxicity , Hydroxybenzoates/antagonists & inhibitors , Hydroxybenzoates/pharmacology , Indazoles/pharmacology , Mice , Signal Transduction/drug effects
3.
Rev Inst Med Trop Sao Paulo ; 47(5): 263-6, 2005.
Article in English | MEDLINE | ID: mdl-16302109

ABSTRACT

The mechanisms used by Paracoccidioides brasiliensis to survive into phagocytic cells are not clear. Cellular iron metabolism is of critical importance to the growth of several intracellular pathogens whose capacity to multiply in mononuclear phagocytes is dependent on the availability of intracellular iron. Thus, the objective of this paper was to investigate the role of intracellular iron in regulating the capacity of P. brasiliensis yeast cells to survive within human monocytes. Treatment of monocytes with deferoxamine, an iron chelator, suppressed the survival of yeasts in a concentration-dependent manner. The effect of deferoxamine was reversed by iron-saturated transferrin (holotransferrin) but not by nonsaturated transferrin (apotransferrin). These results strongly suggest that P. brasiliensis survival in human monocytes is iron dependent.


Subject(s)
Apoproteins/pharmacology , Deferoxamine/pharmacology , Monocytes/microbiology , Paracoccidioides/drug effects , Siderophores/pharmacology , Transferrin/pharmacology , Deferoxamine/antagonists & inhibitors , Humans , Iron/physiology , Paracoccidioides/physiology , Siderophores/antagonists & inhibitors
4.
Rev. Inst. Med. Trop. Säo Paulo ; 47(5): 263-266, Sept.-Oct. 2005.
Article in English | LILACS | ID: lil-417084

ABSTRACT

Os mecanismos utilizados pelo Paracoccidioides brasiliensis para sobreviver em células fagocitárias ainda não estão elucidados. O metabolismo celular férrico é muito importante para o crescimento de inúmeros patógenos intracelulares cuja capacidade de se multiplicarem em fagócitos mononucleares é dependente da disponibilidade intracelular do íon ferro. Assim, o objetivo deste trabalho foi investigar o papel do ferro intracelular sobre a capacidade do P. brasiliensis sobreviver em monócitos humanos. O tratamento de monócitos com deferoxamina, uma droga quelante, diminuiu a sobrevivência de leveduras do fungo de forma dose-dependente. O efeito inibidor da deferoxamina sobre a sobrevivência do P. brasiliensis foi revertido por transferrina saturada com ferro (holotransferrina) mas não por transferrina insaturada (apotransferrina). Estes resultados sugerem que a sobrevivência do P. brasiliensis em monócitos humanos é dependente do íon ferro.


Subject(s)
Humans , Apoproteins/pharmacology , Deferoxamine/pharmacology , Monocytes/microbiology , Paracoccidioides/drug effects , Siderophores/pharmacology , Transferrin/pharmacology , Deferoxamine/antagonists & inhibitors , Iron/physiology , Paracoccidioides/physiology , Siderophores/antagonists & inhibitors
5.
Cell Immunol ; 220(2): 96-106, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12657244

ABSTRACT

Iron is an essential element for the neoplastic cell growth, and iron chelators have been tested for their potential anti-proliferative and cytotoxic effects. To determine the mechanism of cell death induced by iron chelators, we explored the pathways of the three structurally related mitogen-activated protein (MAP) kinase subfamilies during apoptosis induced by iron chelators. We report that the chelator deferoxamine (DFO) strongly activates both p38 MAP kinase and extracellular signal-regulated kinase (ERK) at an early stage of incubation, but slightly activates c-Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) at a late stage of incubation. Among three MAP kinase blockers used, however, the selective p38 MAP kinase inhibitor SB203580 could only protect HL-60 cells from chelator-induced cell death, indicating that p38 MAP kinase serves as a major mediator of apoptosis induced by iron chelator. DFO also caused release of cytochrome c from mitochondria and induced activation of caspase 3 and caspase 8. Interestingly, treatment of HL-60 cells with SB203580 greatly abolished cytochrome c release, and activation of caspase 3 and caspase 8. Collectively, the current study reveals that p38 MAP kinase plays an important role in iron chelator-mediated cell death of HL-60 cells by activating downstream apoptotic cascade that executes cell death pathway.


Subject(s)
Apoptosis/physiology , Deferoxamine/pharmacology , Iron Chelating Agents/pharmacology , Iron/metabolism , Mitogen-Activated Protein Kinases/metabolism , Animals , Apoptosis/drug effects , Caspase 3 , Caspase 8 , Caspase 9 , Caspases/metabolism , Cytochrome c Group/metabolism , Deferoxamine/antagonists & inhibitors , Enzyme Activation , Enzyme Inhibitors/pharmacology , HL-60 Cells , Humans , Imidazoles/pharmacology , Intracellular Membranes/drug effects , Intracellular Membranes/physiology , Iron/antagonists & inhibitors , Jurkat Cells/enzymology , Jurkat Cells/metabolism , Membrane Potentials/drug effects , Membrane Potentials/physiology , Mice , Mitochondria/drug effects , Mitochondria/physiology , Pyridines/pharmacology , Signal Transduction/drug effects , Signal Transduction/physiology , p38 Mitogen-Activated Protein Kinases
6.
Proc Soc Exp Biol Med ; 152(2): 249-52, 1976 Jun.
Article in English | MEDLINE | ID: mdl-935189

ABSTRACT

The influence of vitamin E on the mobilization and excretion of storage iron induced by DF was studied in normal and iron-overloaded rats. Vitamin E administration in pharmacologic doses resulted in complete inhibition of the effect of DF on storage iron in iron-overloaded rats while no such effect could be demonstrated in rats with normal iron stores. The mechanism of the observed inhibition of DF action by vitamin E is at present unknown. Nevertheless this drug interaction has to be considered in view of ongoing therapeutic trials where both antioxidants and iron chelating drugs are administered simultaneously to thalassemic patients with transfusion induced iron overload.


Subject(s)
Deferoxamine/pharmacology , Iron/metabolism , Vitamin E/pharmacology , Animals , Deferoxamine/antagonists & inhibitors , Deferoxamine/therapeutic use , Female , Ferritins/metabolism , Iron/blood , Iron/urine , Liver/metabolism , Rats , Spleen/metabolism , Thalassemia/therapy , Vitamin E/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...